2.345USD-8.40%Mkt Cap: 301.74M USDP/E: —Last update: 2026-06-01
Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States. Its advanced w…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap301.74M USD
Enterprise Value446.97M USD
Revenue (TTM)514.70M USD
Gross Profit425.51M USD
Net Income (TTM)37.03M USD
Revenue/Share4.049 USD
Last Price2.345 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees854
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS68621F1021
Valuation
P/E (Trailing)—
P/E (Forward)-9.35
PEG—
EV/EBITDA10.93
EV/Revenue0.87
P/S0.64
P/B1.09
EPS (TTM)-0.12
EPS (Forward)-0.28
52W Range
2.0406% of range7.077
52W High7.077 USD
52W Low2.040 USD
Profitability
Gross Margin75.57%
Oper. Margin-174.69%
EBITDA Margin7.95%
Profit Margin6.58%
ROE8.53%
ROA6.19%
Growth
Revenue Growth-57.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.31M USD
CapEx (TTM)14.15M USD
FCF Margin5.07%
FCF Yield8.65%
Net Debt-20.52M USD
Net Debt/EBITDA-0.50
Balance Sheet
Debt/Equity0.19
Current Ratio3.53
Quick Ratio2.74
Book Value/Sh2.364 USD
Cash/Share0.7100 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)3.000 USD
Target Range3.000 USD – 3.000 USD
# Analysts1
Ownership
Shares Out.128.67M
Float57.38M
Insiders47.46%
Institutions49.78%
Short Interest
Short Ratio10.8d
Short % Float19.83%
Short % Out.12.61%
Shares Short16.23M
Short (prev mo.)13.10M
Technical
SMA 502.447 (-4.2%)
SMA 2003.932 (-40.4%)
Beta1.31
S&P 52W Chg27.94%
Avg Vol (30d)1.27M
Avg Vol (10d)1.45M
Technical Indicators
RSI (14)51.3
MACD0.0306
MACD Signal0.0185
MACD Hist.+0.0121
BB Upper2.750 USD
BB Middle2.542 USD
BB Lower2.333 USD
BB Width16.44%
ATR (14)0.1617 USD
Vol Ratio (20d)0.53x